Vladimir Sherbukhin

Discovery of a Potent, Orally Available, and Isoform-Selective Retinoic Acid β2 Receptor Agonist

Birgitte W. Lund, Fabrice Piu, Natalie K. Gauthier et al. · Journal of Medicinal Chemistry · 2005 · 63 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Orally Available +15

Chemical information management in drug discovery: optimizing the computational and combinatorial chemistry interfaces

Tudor I. Oprea, Johan Gottfries, Vladimir Sherbukhin et al. · Journal of Molecular Graphics and Modelling · 2000 · 57 citations

Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor

Matthew Coates, Daniel Brookes, Young‐In Kim et al. · Antimicrobial Agents and Chemotherapy · 2017 · 51 citations · Full text

Discovery of Potent and Selective Small-Molecule PAR-2 Agonists

Jimmi Gerner Seitzberg, A. Knapp, Birgitte W. Lund et al. · Journal of Medicinal Chemistry · 2008 · 36 citations · Full text

Par-2 Antagonists, Signal Transduction, Molecular Physiology +15

Novel Potent and Efficacious Nonpeptidic Urotensin II Receptor Agonists

Fredrik Lehmann, Anna Pettersen, Erika A. Currier et al. · Journal of Medicinal Chemistry · 2006 · 29 citations · Full text